| |
| |
| Exchange: |
American Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
2,587,000 |
| Market
Cap: |
7.50(K) |
| Last
Volume: |
19,638 |
Avg
Vol: |
19,583 |
| 52
Week Range: |
$0.0029 - $0.0029 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile RespireRx Pharmaceuticals is developing treatment options including obstructive sleep apnea, attention deficit hyperactivity disorder and recovery from spinal cord injury, as well as certain neurological orphan diseases such as Fragile X Syndrome. Co. is also developing a pipeline of drug products based on its patent portfolios across two drug platforms: cannabinoids, which include dronabinol; and neuromodulators, which include ampakines, proprietary compounds that positively modulate alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid glutamate-type glutamate receptors to promote neuronal function and positive allosteric modulators of the gamma-amino-butyric acid type A receptors.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Margolis Jeff Eliot |
SVP, CFO, Secrety & Treasurer |
• • • |
2020-09-30 |
4 |
A |
$0.00 |
$0 |
I/I |
101,905,382 |
5,142,351 |
|
- |
|
| Jones Timothy L. |
CEO and President |
• • – |
2020-09-30 |
4 |
A |
$0.00 |
$0 |
D/D |
4,409,063 |
4,409,063 |
|
- |
|
| Margolis Jeff Eliot |
SVP, CFO, Secretary & Teasurer |
• • • |
2020-03-22 |
4 |
GA |
$0.00 |
$0 |
I/I |
4,500,000 |
125,207 |
|
- |
|
| Margolis Jeff Eliot |
SVP, CFO, Secretary & Teasurer |
• • • |
2020-03-22 |
4 |
GD |
$0.00 |
$0 |
D/D |
4,500,000 |
0 |
|
- |
|
| Margolis Jeff Eliot |
SVP, CFO, Secretary & Teasurer |
• • • |
2020-03-22 |
4 |
A |
$0.00 |
$0 |
D/D |
4,500,000 |
4,500,000 |
|
- |
|
| Lippa Arnold |
Exec. Chairman, CEO, CSO |
• • – |
2020-03-22 |
4 |
GD |
$0.00 |
$0 |
D/D |
4,500,000 |
598 |
|
- |
|
| Lippa Arnold |
Exec. Chairman, CEO, CSO |
• • – |
2020-03-22 |
4 |
A |
$0.00 |
$0 |
D/D |
4,500,000 |
4,500,598 |
|
- |
|
| Lippa Arnold |
Exec Chairman, CSO |
• • – |
2018-09-12 |
4 |
GD |
$0.00 |
$0 |
D/D |
47,620 |
0 |
|
- |
|
| Lippa Arnold |
Exec Chairman, CSO |
• • – |
2018-09-12 |
4 |
B |
$0.00 |
$0 |
D/D |
47,620 |
47,620 |
2.73 |
- |
|
| Manuso James S J |
President and CEO |
• • – |
2017-09-13 |
4 |
B |
$0.00 |
$0 |
D/D |
1,097 |
74,252 |
2.73 |
- |
|
| Margolis Jeff Eliot |
VP, Treasurer & Secretary |
• • – |
2016-07-15 |
4 |
GA |
$0.00 |
$0 |
I/I |
15,134,944 |
4,000,000 |
|
- |
|
| Margolis Jeff Eliot |
VP, Treasurer & Secretary |
• • – |
2016-07-15 |
4 |
GD |
$0.00 |
$0 |
I/I |
5,000,000 |
0 |
|
- |
|
| Margolis Jeff Eliot |
VP, Treasurer & Secretary |
• • – |
2016-07-15 |
4 |
GD |
$0.00 |
$0 |
D/D |
10,134,944 |
0 |
|
- |
|
| Margolis Jeff Eliot |
VP, Treasurer & Secretary |
• • – |
2016-06-16 |
4 |
A |
$0.00 |
$0 |
I/I |
5,000,000 |
5,000,000 |
|
- |
|
| Margolis Jeff Eliot |
VP, Treasurer & Secretary |
• • – |
2016-06-16 |
4 |
D |
$0.00 |
$0 |
D/D |
(5,000,000) |
10,134,944 |
|
- |
|
| Manuso James S J |
Preident & CEO |
• • – |
2016-04-07 |
4 |
A |
$0.00 |
$0 |
D/D |
11,887,779 |
23,775,558 |
|
- |
|
| Margolis Jeff Eliot |
VP, Treasurer & Secretary |
• • – |
2015-09-14 |
4 |
S |
$0.00 |
$0 |
D/D |
(483,872) |
15,134,944 |
|
- |
|
| Margolis Jeff Eliot |
VP, Treasurer & Secretary |
• • – |
2015-09-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
507,374 |
15,618,816 |
|
- |
|
| Manuso James S J |
President and CEO |
• • • |
2015-08-28 |
4 |
B |
$0.00 |
$0 |
D/D |
11,887,779 |
11,887,779 |
3.15 |
- |
|
| Purcell Richard David Jr. |
SVP - Research and Development |
• – – |
2014-10-15 |
4 |
A |
$0.00 |
$0 |
D/D |
2,000,000 |
2,000,000 |
|
- |
|
| Macfarlane Katie |
Director |
– • – |
2014-09-03 |
4 |
A |
$0.00 |
$0 |
D/D |
2,000,000 |
2,000,000 |
|
- |
|
| Sapirstein James |
Director |
– • – |
2014-09-03 |
4 |
A |
$0.00 |
$0 |
D/D |
2,000,000 |
2,000,000 |
|
- |
|
22 Records found
|
1
|
Page 1 of 1 |
|
|
